Vanguard Group Inc INHIBIKASE THERAPEUTICS INC Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025
Number of Shares
3,224,370
Previous 2,848,663 13.19%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
N/A
375,707 Added 13.19%
3,224,370 $0
Q1 2025

May 09, 2025
BUY
N/A
10,018 Added 0.35%
2,848,663 $0
Q4 2024

Feb 11, 2025
BUY
N/A
2,821,921 Added 16873.48%
2,838,645 $0
Q1 2024

May 10, 2024
SELL
N/A
-65,321 Reduced 79.62%
16,724 $0
Q4 2023

Feb 14, 2024
SELL
N/A
-5,402 Reduced 6.18%
82,045 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-863 Reduced 0.98%
87,447 $0
Q2 2023

Aug 14, 2023
BUY
N/A
88,310 New
88,310 $0
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email